MIT Department of Brain and Cognitive Sciences

Digital Garage Hosts THE NEW CONTEXT CONFERENCE San Francisco 2023 Fall Under the Theme of "Building Useful and Trustworthy AI"

Retrieved on: 
Thursday, October 26, 2023

SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- DG will host THE NEW CONTEXT CONFERENCE San Francisco 2023 Fall (NCC San Francisco 2023 Fall), a conference to discuss "new context" for a digital society, in San Francisco on November 17, 2023.

Key Points: 
  • SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- DG will host THE NEW CONTEXT CONFERENCE San Francisco 2023 Fall (NCC San Francisco 2023 Fall), a conference to discuss "new context" for a digital society, in San Francisco on November 17, 2023.
  • This conference is designed for those interested in exploring cutting-edge Internet technologies and the businesses that emerge around them.
  • The theme of NCC San Francisco 2023 Fall will be "Building Useful and Trustworthy AI" and hosted by Kaoru Hayashi and Joichi Ito, the co-founders of DG, who have been at the forefront of the Internet since its initial stage at "Digital Garage @ 717 Market Street*1" in San Francisco.
  • Venue: Digital Garage @ 717 Market Street (717 Market Street, San Francisco, USA)

Cardlytics Appoints New Chief Financial Officer

Retrieved on: 
Tuesday, July 18, 2023

ATLANTA, July 18, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in bank’s digital channels, is pleased to announce the appointment of Alexis DeSieno as Chief Financial Officer.

Key Points: 
  • ATLANTA, July 18, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in bank’s digital channels, is pleased to announce the appointment of Alexis DeSieno as Chief Financial Officer.
  • DeSieno brings a wealth of experience and expertise in finance and data analytics, and will play a vital role in profitably growing Cardlytics’ business.
  • She will report directly to Karim Temsamani, Chief Executive Officer.
  • In addition to overseeing the budgeting and planning processes, she provided strategic financial analysis and played an important role in CLEAR’s IPO.

NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor

Retrieved on: 
Tuesday, July 11, 2023

Alan Watt, Chief Executive Officer of NodThera, said: “Taken together, these initial findings represent the first unambiguous demonstration of modulation of neuroinflammation in a human population with an NLRP3 inflammasome inhibitor.

Key Points: 
  • Alan Watt, Chief Executive Officer of NodThera, said: “Taken together, these initial findings represent the first unambiguous demonstration of modulation of neuroinflammation in a human population with an NLRP3 inflammasome inhibitor.
  • Subjects in the study were cannulated and CSF-sampled on Day 1 (pre-dose) and Day 7 following daily NT-0796 dosing.
  • CSF drug levels were confirmed as consistent with previous observations and a range of inflammatory CSF biomarkers demonstrated meaningful reductions.
  • NfL is now recognised by the Food and Drug Administration (FDA) as a key biomarker of neuroaxonal damage and neurodegeneration.

Souvenaid Launches a New Memory Supplement with a Unique Nutritional Approach to Help Strengthen Synapses

Retrieved on: 
Monday, April 17, 2023

ROCKVILLE, Md., April 17, 2023 /PRNewswire/ -- Souvenaid, the first and only memory supplement specifically designed to support memory function through a specialized blend of nutrients that help strengthen synapses, was introduced to the U.S. market today by Nutricia.  During normal aging, memory decline is linked to changes in the brain and the functioning of synapses – the brain connections that make it possible to create and recall memories.  One daily four-ounce serving of Souvenaid powers synapses with the right nutrients at the right levels, using its proprietary formula Fortasyn Connect™, which cannot be found in any other memory supplement. Fortasyn Connect is a well-researched blend of key nutrients that are understood to help support synapses in the brain. This combination and concentration of each nutrient is nearly impossible to get from typical diet alone.

Key Points: 
  • Fortasyn Connect is a well-researched blend of key nutrients that are understood to help support synapses in the brain.
  • Souvenaid, the first and only memory supplement specifically designed to support memory function through a specialized blend of nutrients that help strengthen synapses, was introduced to the U.S. market today by Nutricia.
  • Just like calcium strengthens our bones, the nutrients that make up Fortasyn Connect help strengthen how synapses function.
  • Souvenaid was developed based on the knowledge that these are the prerequisites to support new synapses and strengthen existing ones.

MIT's Electric Vehicle Team partners with DMI to create one of the first ever open-source, hydrogen-fuel-cell powered motorcycles

Retrieved on: 
Wednesday, March 29, 2023

The team is advised by Professor Alexander H. Slocum of the MIT Department of Mechanical Engineering.

Key Points: 
  • The team is advised by Professor Alexander H. Slocum of the MIT Department of Mechanical Engineering.
  • DMI is providing a DM15 fuel cell module that will be integrated into a motorcycle that will be designed and developed by the MIT EVT.
  • The module uses hydrogen as a fuel source and converts it into electricity, producing only water vapor as a byproduct.
  • This collaboration is an excellent example of how academia and industry can work together to drive innovation and create a sustainable future.

Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board

Retrieved on: 
Tuesday, January 17, 2023

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).

Key Points: 
  • Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).
  • Cameron Myhrvold Ph.D., co-founder of Carver will serve as the chairman of the SAB.
  • Additional appointments include Uri Lopatin, M.D., Olivia Merkel, Ph.D., and Neville Sanjana, Ph.D.
    “I am thrilled to have Dr. Lopatin, Dr. Merkel and Dr. Sanjana join our advisory board,” said Dr. Walter Strapps, co-founder and CEO of Carver.
  • Dr. Sanjana holds a PhD in Brain and Cognitive Sciences from MIT, a BS in Symbolic Systems and a BA in English from Stanford University.

Association for Computing Machinery Awards Raluca Ada Popa, President and Founder of Opaque Systems and UC Berkeley PhD, the 2021 Grace Murray Hopper Award

Retrieved on: 
Tuesday, July 26, 2022

BERKELEY, Calif. , July 26, 2022 /PRNewswire/ -- Opaque Systems, the company pioneering Confidential AI and Analytics which enables collaborative analytics and AI for confidential computing, today announced its president and co-founder Raluca Ada Popa, MS, PhD, is the recipient of the 2021 AMC Grace Murray Hopper Award. Raluca Ada Popa is recognized for her exceptional impact and contributions to building secure systems focused on protecting the confidentiality of data stored on remote servers including recent open sourced innovation MC2.

Key Points: 
  • The ACM Grace Murray Hopper Award is given to outstanding computer professionals selected on the basis of a single recent major technical or service contribution.
  • This prestigious honor comes at a time when confidential computing is experiencing increasing market demand across Global 2000 organizations.
  • Popa is accelerating innovation with her company, Opaque Systems, that raised its $22M Series A funding in June.
  • "I am delighted to receive the 2021 ACM Grace Murray Hopper award," said Popa.

Record-Breaking Registrants and Technical Papers for 2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR)

Retrieved on: 
Friday, July 1, 2022

LOS ALAMITOS, Calif., July 1, 2022 /PRNewswire/ --  2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), the largest gathering of professionals from across the world and from every aspect of the computer vision, machine learning (ML), and artificial intelligence (AI) industries, successfully concluded this week, breaking records with over 10,250 conference registrants and 2000 technical papers presented.

Key Points: 
  • Unity Computer Vision showcased "Digital Humans for Computer Vision" - a proprietary digital human generator was developed that contains highly-parametric and simulation-ready 3D human assets.
  • The Computer Vision and Pattern Recognition Conference (CVPR) is the premier annual computer vision and pattern recognition conference.
  • The Computer Vision Foundation is a non-profit organization whose purpose is to foster and support research on all aspects of computer vision.
  • Together with the IEEE Computer Society, it co-sponsors the two largest computer vision conferences: CVPR and the International Conference on Computer Vision (ICCV).

CVPR 2022 Program to Reveal New Research on Computer Vision, AI, and Machine Learning at the 19 - 24 June 2022 Global Conference

Retrieved on: 
Wednesday, June 8, 2022

CVPR 2022 conference program summary:

Key Points: 
  • CVPR 2022 conference program summary:
    Hosted by the IEEE Computer Society (IEEE CS) and the Computer Vision Foundation (CVF), CVPR is the premier annual computer vision event comprising the main conference and several co-located workshops and short courses.
  • The Computer Vision and Pattern Recognition Conference (CVPR) is the premier annual computer vision and pattern recognition conference.
  • The Computer Vision Foundation is a non-profit organization whose purpose is to foster and support research on all aspects of computer vision.
  • Together with the IEEE Computer Society, it co-sponsors the two largest computer vision conferences: CVPR and the International Conference on Computer Vision (ICCV).

Social Impact Nonprofit Roivant Social Ventures Announces Leadership Team, Inaugural Partnership, and Publication in Nature Gene Therapy

Retrieved on: 
Tuesday, August 17, 2021

RSV also announced the publication in Nature Gene Therapy of the Global Gene Therapy Working Group's initiative to expand gene therapy access in Africa and India.

Key Points: 
  • RSV also announced the publication in Nature Gene Therapy of the Global Gene Therapy Working Group's initiative to expand gene therapy access in Africa and India.
  • Lindsay Androski, JD, MBA, CFA is the Founder, President and CEO of Roivant Social Ventures.
  • "Gene therapy, and other advanced therapies, offer patients hope far beyond most current treatment methods," said Ms. Androski.
  • Roivant Social Ventures (RSV) is a not-for-profit social impact organization founded by Roivant Sciences focused on improving healthcare access and outcomes for underserved groups.